PriceTargets.com logo

LON:SPEC - Inspecs Group Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: GBX 0
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
GBX 405 As of 09/17/2021 04:07 PM ET
+0.30 (1.20%)

This chart shows the closing price for SPEC by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Inspecs Group Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SPEC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SPEC

Analyst Price Target is GBX 0
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Inspecs Group in the last 3 months. The average price target is GBX 0, with a high forecast of GBX 0 and a low forecast of £100,000. The average price target represents a -100.00% upside from the last price of GBX 405.

This chart shows the closing price for SPEC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in Inspecs Group. This rating has held steady since June 2021, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/28/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/26/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/24/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/23/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/23/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/21/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/20/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/19/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
7/10/2020Peel HuntReiterated RatingBuy
5/12/2020Peel HuntReiterated RatingBuy
(Data available from 9/20/2016 forward)

News Sentiment Rating

0.31 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/22/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/24/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/23/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/23/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/22/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/22/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/21/2021
  • 1 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
9/20/2021

Current Sentiment

  • 1 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

  • No positive mentions tracked during this time.

Very Positive

Inspecs Group

Inspecs Group PLC designs, produces, sells, markets, and distributes fashion eyewear and original equipment manufacturer products worldwide. It provides a range of branded and private label optical and sunglasses frames. Inspecs Group PLC offers its products directly to retailers, distributors, and brand partners. The company also sells its products through a network of approximately 70,000 points of sale in 80 countries worldwide. Inspecs Group PLC was founded in 1988 and is headquartered in Bath, the United Kingdom.
Read More

Today's Range

Now: GBX 405
Low: 403
High: 407.30

50 Day Range

MA: GBX 383.63
Low: 357
High: 407

52 Week Range

Now: GBX 405
Low: 167.60
High: 638

Volume

172,135 shs

Average Volume

78,793 shs

Market Capitalization

£410.23 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Inspecs Group?

The following Wall Street research analysts have issued stock ratings on Inspecs Group in the last year:
View the latest analyst ratings for SPEC.

What is the current price target for Inspecs Group?

0 Wall Street analysts have set twelve-month price targets for Inspecs Group in the last year. has the lowest price target set, forecasting a price of £100,000 for Inspecs Group in the next year.
View the latest price targets for SPEC.

What is the current consensus analyst rating for Inspecs Group?

Inspecs Group currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for SPEC.

What other companies compete with Inspecs Group?

Other companies that are similar to Inspecs Group include Advanced Medical Solutions Group, CRH Medical, Tristel, Bovie Medical, Omega Diagnostics Group, TSO3, Akers Biosciences, Vigil Health Solutions, Relevium Technologies, Ambu A/S, Ansell, Ansell, Ansell, Austco Healthcare and BATM Advanced Communications.

How do I contact Inspecs Group's investor relations team?

The company's listed phone number is 44 1125 717 000. The official website for Inspecs Group is inspecs.com.